MUC16 and neoplasm: At present, the assessment of chemotherapy sensitivity in patients with endometrial cancer mainly depends on the clinical experience of the tumor physicians based on physical examination, gynecological examination, medical imaging techniques, including magnetic resonance imaging, computed tomography 8, or the identification of tumor biomarkers, such as cancer antigen 125 9, 10.